STAKEHOLDERS have until 27 Sep to provide feedback on the revised draft of the 2022 National Medicines Policy (NMP) Review.
The consultation process follows Minister for Health and Aged Care, Mark Butler's announcement at the Pharmaceutical Society of Australia's (PSA's) Conference last month, that he had asked Deputy Chief Medical Officer, Professor Michael Kidd, to restart the NMP review.
The initial review had originally been scheduled to conclude on 16 Feb, but the initial consultation period was extended by former Health Minister, Greg Hunt, until after the Federal election in Mar (PD 25 Mar).
The NMP Review Committee noted that stakeholders had "broadly agreed with most components of the initial consultation draft 2022 NMP", but said they had called for consistency in the language and phrasing of the document.
In addition to providing feedback on the revised draft NMP 2022, through a survey, Kidd will host six targeted consultation sessions for specific stakeholder groups, including the pharmacy sector.
An initial prescriber session is scheduled to take place tomorrow afternoon, hosted on virtual meeting platform, Webex.
Members of the pharmacy sector will be invited to share their views during an hour-long online meeting at 3pm (AEST) on 15 Sep.
Stakeholders can register their interest in attending the session by emailing NMP@health.gov.au before 13 Sep, with the subject line - EOI Session E - Pharmacy sector - and providing their full name, organisation and email address.
A meeting invitation with Webex details will be provided on 14 Sep.
The above article was sent to subscribers in Pharmacy Daily's issue from 23 Aug 22
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 23 Aug 22
